The project will assess the effectiveness and impact of HIV point-of-care tests for assessment of CD4 count and early infant diagnosis in China and PNG.
Burnet Institute’s Centre for International Health is celebrating its first-ever National Health and Medical Research Council (NHMRC) Project Grant, receiving more than $900,000 to address HIV novel point-of-care (POC) tests and early infant diagnosis in Papua New Guinea and China.
This research is a world-first intervention study to assess the effectiveness and impact of two newly-developed and unique low-cost, POC tests for assessment of CD4 count and early infant diagnosis of HIV.
Assessing CD4 count in HIV-infected patients is crucial in determining whether that patient needs to go on life-saving treatment.
Burnet Institute Director and CEO, Professor Brendan Crabb said the NHMRC project grant is a wonderful outcome for the Institute.
“It marks an important milestone in the integration of cutting edge research into traditional development aid programs,” Professor Crabb said.
The project will be a collaboration between all three of the Institute’s Centres and will include the use of VISITECT CD4®, a test developed by Burnet.
It will be led by Burnet Maternal and Child Health Team Leader, Associate Professor Stanley Luchters with Professor Suzanne Crowe AM, Associate Professor Mark Stoové, Associate Professor David Anderson, Dr Jessica Markby and Dr Claire Ryan.
External collaborators include Dr Angela Kelly and Associate Professor Andrew Vallely from the University of New South Wales, Professor Xiang-sheng Chen from China’s National Centre for Sexually Transmitted Diseases and Professor David Kelso from Northwestern University in the USA.